Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 April 2022 | Story Leonie Bolleurs | Photo Supplied
WJ swart
Prof Wijnand Swart believes a ‘systems level understanding’ of phytobiomes (consisting of plants, their environment, and all their associated organisms) will enable us to produce sufficient crops to meet global demands while minimising negative impacts on our environment.

Plant health is important for the survival of our planet and all its living creatures. Now, imagine an instrument that contains a DNA chip from virtually every known plant pathogen, where one can simply snip off a piece of the infected plant material, slip it into the ‘plant disease tricorder’, and within seconds you have not only a diagnosis of the disease, but all the information about its control too.

According to Prof Wijnand Swart, Professor of Plant Pathology in the Department of Plant Sciences at the University of the Free State (UFS) and President of the Southern African Society for Plant Pathology (SASPP), this concept might be a bit far-fetched, but is a distinct possibility for the not-too-distant future. “Without a doubt …,” he believes.

He was recently a guest on a series of radio talks on plant health in South Africa, hosted by the National Science and Technology Forum (NSTF) in partnership with Plaas/Farm TV (YouTube broadcaster). His talk on the topic, Whither (or wither) Plant Pathology in the next 50 years, was specifically focused on understanding the latest research and dynamics of the discipline in a South African context.

In terms of this futuristic perspective, he says collaboration between plant pathologists and biomedical and aeronautical engineers, nanotechnologists, and computer scientists will aid the development of micro-sensory technologies for the detection of new plant diseases that are relevant to biosecurity, plant disease diagnostics, and epidemiological modelling.

In his discussion, Prof Swart referred to the work of Prof John Lucas, former Head of Plant Pathology and Microbiology at the Rothamsted Research Station in the United Kingdom, who believes that there are three key issues facing plant pathologists in the 21st century. These are the strengthening of food security while simultaneously safeguarding the health of associated ecosystems and reducing the dependency on natural resources; the creation of pest and disease control systems that are sustainable and not compromised by the evolution of pest and pathogen strains; and the development of suitable crop protection technologies.

Future technologies

Based on the work of Prof Lucas, Prof Swart states that future technologies in plant health will develop in five areas. In the first area, he says DNA-based technologies will greatly increase the speed, sensitivity, and accuracy of pest and pathogen detection and diagnosis.

Also key here, is the integration of nanomaterials into disease management strategies and diagnostics. He says in the past decade, the use of nanotechnology in phytopathology has grown exponentially. According to him, nanotechnology can increase productivity using nano-pesticides and nano-fertilisers, improve soil quality by means of nano-zeolites and hydrogels, stimulate plant growth using nanomaterials, and provide smart monitoring via nano-sensors and wireless communication devices.

Prof Swart says according to Prof Lucas, the second area in which plant health technologies will grow is plant defence and immunity. When induced, plant resistance primes plants to deal with a diversity of biotic and abiotic stresses. Prospects of inducing chemically modulated plant resistance via biological agents (such as engineered microbes), might result in low-cost seed treatments, thereby removing the need for expensive chemical spray regimes.

Technology development in plant health will also become more evident in genetic diversification. Prof Swart believes sequencing the genomes of major crop species and their wild relatives will expand the known gene pool and diversify genetic resources available to plant breeders.

According to him, a new era is beckoning, where the prospect of crop pharmacology based on signal molecules and their receptors will become a reality. It will be based on the development of novel chemistries designed to manipulate specific molecular targets, by either regulating host resistance or disabling the disease-causing processes of pathogens.

The fifth area in which plant health technologies will develop, is ecological approaches to disease control. He says by understanding the ecology of pathogens, our ability to exploit their natural enemies will improve. Ecological approaches to plant disease control will have a significant impact on the introduction of invasive pathogen species, while the effect of climate change will influence the emergence of new plant diseases and epidemics. He strongly believes that it is important to take a holistic approach to understanding how and why plant pathogenesis occurs if we are to manage diseases effectively.

Future challenges

The development of these new technologies is very important, as there are several challenges that plant pathology will face in the future. These include the increasing demand for food to support the growing global population; the decreasing production potential of agriculture due to competition for fertile land; the increased risk of plant disease epidemics resulting from agricultural intensification; the depletion of natural resources; and the influence of climate change on interactions between plants and their pests or pathogens.

Prof Swart believes a ‘systems level understanding’ of phytobiomes (consisting of plants, their environment, and all their associated organisms) will enable us to produce sufficient crops to meet global demands while minimising negative impacts on our environment.

He concludes, saying that plant pathology will evolve as an interdisciplinary science. He adds that future research will focus on new problems that are traditionally seen as outside the core discipline of plant pathology. Furthermore, food security will be a dominant and important driver of plant pathology research, while the impact of climate change on plant diseases will be very significant. Finally, that the adaptive potential of plant and pathogen populations will be one of the most important predictors of the magnitude of climate change effects.

LISTEN: radio interview


News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept